Skip to main content

Beneficial ownership — 13D / 13G

87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Balyasny Asset Management L.P. EHAB Enhabit, Inc. 13G/A 5.22% 6mo
LMR Partners LLP PTOR Praetorian Acquisition Corp. 13G 6.1% 6mo
METEORA CAPITAL, LLC SELXF Semilux International Ltd. 13G/A 7.64% 6mo
Kynam Capital Management, LP CTMX CytomX Therapeutics, Inc. 13G/A 6.9% 6mo
EVENTIDE ASSET MANAGEMENT, LLC OVID Ovid Therapeutics Inc. 13G 7.3% 6mo
ARMISTICE CAPITAL, LLC IMNN Imunon, Inc. 13G/A 9.99% 6mo
CVI Investments, Inc. ATOM Atomera Inc 13G/A 0% 6mo
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC NCMI National CineMedia, Inc. 13G/A 8.48% 6mo
Encompass Capital Advisors LLC AESI Atlas Energy Solutions Inc. 13G/A 7.36% 6mo
WELLINGTON MANAGEMENT GROUP LLP BRCB Black Rock Coffee Bar, Inc. 13G/A 0% 6mo
Westchester Capital Management, LLC MMTX Miluna Acquisition Corp 13G 5.05% 6mo
Nantahala Capital Management, LLC EB Eventbrite, Inc. Class A Common Stock 13G/A 0% 6mo
ARMISTICE CAPITAL, LLC VSTM Verastem, Inc. 13G/A 5.23% 6mo
Peter E. Haas, Jr. LEVI Levi Strauss & Co 13G/A 5.5% 6mo
Ning Ding ZJK ZJK Industrial Co., Ltd. 13G/A 59.62% 6mo
Innovation Endeavors III LP EIKN Eikon Therapeutics, Inc. 13G 5% 6mo
Orbis Investment Management Limited MICC Magnum Ice Cream Co N.V. 13G 5.1% 6mo
VAN ECK ASSOCIATES CORP OR OR Royalties Inc. 13G/A 5.74% 6mo
JANUS HENDERSON GROUP PLC OSIS Osi Systems Inc 13G/A 4.7% 6mo
Capitalink Ltd. CMND Clearmind Medicine Inc. 13G/A 0% 6mo
MACKENZIE FINANCIAL CORP CSIQ Canadian Solar Inc. 13G 6.9% 6mo
ROYAL BANK OF CANADA BIP Brookfield Infrastructure Partners Inc. 13G/A 4.37% 6mo
Neos Partners, LP FPS Forgent Power Solutions, Inc. 13G 67.5% 6mo
PRICE T ROWE ASSOCIATES INC /MD/ RVTY Revvity, Inc. 13G/A 9% 6mo
ARMISTICE CAPITAL, LLC BJDX Bluejay Diagnostics, Inc. 13G/A 4.99% 6mo
ARMISTICE CAPITAL, LLC CHRN ChronoScale Holdings Corp 13G/A 4.99% 6mo
Magnetar Financial LLC WHLR Wheeler Real Estate Investment Trust, Inc. 13G/A 45% 6mo
Caligan Partners LP FTH Faeth Therapeutics, Inc. 13G 9.4% 6mo
Select Equity Group, L.P. MIDD MIDDLEBY Corp 13G/A 3.3% 6mo
Portolan Capital Management, LLC CSTL Castle Biosciences Inc 13G/A 4.45% 6mo
Orbis Investment Management Limited RHI Robert Half Inc. 13G 7.5% 6mo
Fourthstone LLC MNSB MainStreet Bancshares, Inc. 13G/A 5.22% 6mo
Vestal Point Capital, LP ANRO Alto Neuroscience, Inc. 13G/A 6.5% 6mo
ARMISTICE CAPITAL, LLC AVNS Avanos Medical, Inc. 13G/A 4.3% 6mo
T. Rowe Price Investment Management, Inc. AMBQ Ambiq Micro, Inc. 13G 6% 6mo
1607 Capital Partners, LLC GF New Germany Fund Inc 13G/A 6.57% 6mo
WELLINGTON MANAGEMENT GROUP LLP DRI Darden Restaurants Inc 13G/A 6% 6mo
T. Rowe Price Investment Management, Inc. VSEC Vse Corp 13G/A 9.7% 6mo
T. Rowe Price Investment Management, Inc. BRCC BRC Inc. 13G/A 0% 6mo
Orbis Investment Management Limited ICLR Icon PLC 13G/A 0% 6mo
CoinFund Management LLC ORBS Eightco Holdings Inc. 13G/A 6.1% 6mo
Alyeska Investment Group, L.P. DFLI Dragonfly Energy Holdings Corp. 13G/A 6.18% 6mo
VIKING GLOBAL INVESTORS LP ADPT Adaptive Biotechnologies Corp 13G/A 18.8% 6mo
COHEN & STEERS, INC. AKR Acadia Realty Trust 13G/A 12.41% 6mo
Point72 Asset Management, L.P. XLO Xilio Therapeutics, Inc. 13G/A 0% 6mo
T. Rowe Price Investment Management, Inc. FTI TechnipFMC plc 13G/A 4.2% 6mo
Greycroft Partners II, L.P. MNTN MNTN, Inc. 13G/A 6.4% 6mo
ARMISTICE CAPITAL, LLC KYNB Kyntra Bio, Inc. 13G/A 9.88% 6mo
Vestal Point Capital, LP IMTX Immatics N.V. 13G/A 4.6% 6mo
LMR Partners LLP SORN Soren Acquisition Corp. 13G 6.5% 6mo